{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3543, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide presents two distinct tables: one for cash flow (left) and one for net debt (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/16", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "22eea064-9493-4637-bd32-f7ea13acb83f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Financial development and cash flow sections", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "summarize", "notes": "The forecast range is SEK 7,000 – 9,000 million.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/17", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "section_divider", "function": "transition", "notes": "The background image is highly stylized and dark, contrasting with the simple, bold white text.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/18", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-18", "loopMatches": [ { "to": 22, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6aa348d3-a41e-4bd0-b083-8c15d563d7c7", "evidence": "Q1 update on the restructuring program and program focus areas sections", "position": 0, "objective": "What are the consequences of not completing the restructuring program?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/19", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-19", "loopMatches": [ { "to": 22, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6aa348d3-a41e-4bd0-b083-8c15d563d7c7", "evidence": "Q1 update on the restructuring program and program focus areas sections", "position": 0, "objective": "What are the consequences of not completing the restructuring program?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide outlines specific financial targets for the Embracer Group restructuring program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/20", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-20", "loopMatches": [ { "to": 22, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6aa348d3-a41e-4bd0-b083-8c15d563d7c7", "evidence": "Q1 update on the restructuring program and program focus areas sections", "position": 0, "objective": "What are the consequences of not completing the restructuring program?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "a8f251b4-4cd2-4e79-9d56-7a36bd5c65ee", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Reminder of objectives and program focus areas sections", "position": 2, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a horizontal bar chart style to represent a phased timeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/21", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-21", "loopMatches": [ { "to": 22, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6aa348d3-a41e-4bd0-b083-8c15d563d7c7", "evidence": "Q1 update on the restructuring program and program focus areas sections", "position": 0, "objective": "What are the consequences of not completing the restructuring program?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "a8f251b4-4cd2-4e79-9d56-7a36bd5c65ee", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Reminder of objectives and program focus areas sections", "position": 2, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "executive_summary", "function": "summarize", "notes": "Part of a Q1 update presentation for Embracer Group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/22", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-22", "loopMatches": [ { "to": 22, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6aa348d3-a41e-4bd0-b083-8c15d563d7c7", "evidence": "Q1 update on the restructuring program and program focus areas sections", "position": 0, "objective": "What are the consequences of not completing the restructuring program?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "a8f251b4-4cd2-4e79-9d56-7a36bd5c65ee", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Reminder of objectives and program focus areas sections", "position": 2, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "transition", "function": "transition", "notes": "The background features a stylized 'A' shape composed of various photos of employees/work environments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/23", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/24", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-877c-72c9-8ffc-8b909cac4087", "docSlug": "873727db0e38c997ae103baa092e5974", "documentTitle": "Embracer Group | Results Presentation Deck | 25 slides", "authorId": "embracer-group", "authorName": "Embracer Group", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-877c-72c9-8ffc-8b909cac4087/25", "deckHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087", "deckAnchorHref": "/decks/019de075-877c-72c9-8ffc-8b909cac4087#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/E6ZO4ZlBtX32Tf2LFO0fe_LV1h_yLdB-z1H2Zn-vrZA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82YTU3Y2NmNTcxZjIwNWFjYTljNGMxMDUwNjk2YjNlZC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/1", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/yC1tY6nNlBORV7lKbzQu1FJhn2oE7paIyuZu5kyGj5g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82YTU3Y2NmNTcxZjIwNWFjYTljNGMxMDUwNjk2YjNlZC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/X5xos0ix1TdQSD_VMX2F1VvNivGZL2vCzOGg_6Qc85I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82YTU3Y2NmNTcxZjIwNWFjYTljNGMxMDUwNjk2YjNlZC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/kAgJK2ri-Q769AqD8V3cguofbbU_AhWBo1MDIKwr0G4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82YTU3Y2NmNTcxZjIwNWFjYTljNGMxMDUwNjk2YjNlZC9wMDAxLnBuZw" }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/2", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/3", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "mission", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/4", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a visual metaphor of donor vs patient cells to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/5", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a chevron-based process flow to map disease states to market validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/6", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "business_model", "function": "present_solution", "notes": "The slide uses a flow-based diagram to show how pipeline assets are developed and then monetized through various business strategies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/7", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style timeline to show progress of various therapeutic programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/8", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "team_bio", "function": "other", "notes": "The slide uses a card-based layout to display five key executives with their titles and previous company affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/9", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/10", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "team_bio", "function": "cite_precedent", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/11", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/12", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "testimonial", "function": "cite_precedent", "notes": "The slide uses a quote from a subject matter expert to build credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/13", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a biological process diagram to illustrate the mechanism of immune activation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/14", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-14", "loopMatches": [ { "to": 15, "from": 14, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "2cbc1c6d-c733-424a-ac36-0b9c4e6d4b36", "evidence": "Slides 14-15 emphasize the limitations of current treatments and the potential for Renovaro Biosciences' solutions.", "position": 0, "objective": "Highlight the need for better treatments for cancer and infectious diseases", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 15, "from": 14, "beatId": "a78bec52-bf24-498a-aca5-e5a3d1fbc3bf", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 14-15 highlight the inadequacy of adaptive immunity for cancer and the ability of tumor cells to evade the immune response.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a visual comparison to illustrate two distinct evasion strategies: starving killer T-cells and recruiting protective T-reg cells.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/15", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-15", "loopMatches": [ { "to": 15, "from": 14, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "2cbc1c6d-c733-424a-ac36-0b9c4e6d4b36", "evidence": "Slides 14-15 emphasize the limitations of current treatments and the potential for Renovaro Biosciences' solutions.", "position": 0, "objective": "Highlight the need for better treatments for cancer and infectious diseases", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 15, "from": 14, "beatId": "a78bec52-bf24-498a-aca5-e5a3d1fbc3bf", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 14-15 highlight the inadequacy of adaptive immunity for cancer and the ability of tumor cells to evade the immune response.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "solution", "function": "present_solution", "notes": "The diagram uses a callout-style list to map specific cellular functions to a central dendritic cell illustration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/16", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 16, "beatId": "275086f9-ef30-45ca-b745-96007973fd09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 16-17 introduce Renovaro Biosciences' gene-enhanced dendritic cells and cutting-edge personalized cancer therapy.", "position": 1, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular process flow to represent the manufacturing cycle of a personalized cell therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/17", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 16, "beatId": "275086f9-ef30-45ca-b745-96007973fd09", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 16-17 introduce Renovaro Biosciences' gene-enhanced dendritic cells and cutting-edge personalized cancer therapy.", "position": 1, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Includes statistical significance markers (p-values) and sample sizes (n).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/18", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-18", "loopMatches": [ { "to": 19, "from": 18, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "27235964-c346-4f82-b85b-b5b33f94e7cf", "evidence": "Slides 18-19 present data on RENB-DC-11's ability to reduce pancreatic tumor size in humanized mice.", "position": 1, "objective": "Showcase promising results for RENB-DC-11", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_disclosure", "function": "appendix", "notes": "The slide acts as a pointer to a specific external scientific presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/19", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-19", "loopMatches": [ { "to": 19, "from": 18, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "27235964-c346-4f82-b85b-b5b33f94e7cf", "evidence": "Slides 18-19 present data on RENB-DC-11's ability to reduce pancreatic tumor size in humanized mice.", "position": 1, "objective": "Showcase promising results for RENB-DC-11", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a ribbon-style process diagram to show progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/20", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/21", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/22", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/23", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "section_divider", "function": "transition", "notes": "The slide features the Renovaro Biosciences logo and a stylized botanical/cellular graphic background.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/24", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to explain the therapeutic intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/25", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a chevron-style process flow to represent chronological progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/26", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/27", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/28", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a significant drop in viral load starting around day 14, stabilizing at a low level from day 145 onwards.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/29", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/30", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/31", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/32", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/33", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/34", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a comparative diagram to illustrate the selective mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/35", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a ribbon-style process diagram to represent sequential or cumulative progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/36", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "testimonial", "function": "cite_precedent", "notes": "The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/37", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/38", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/39", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/40", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a horizontal arrow-based timeline structure to map specific drug candidates to their upcoming regulatory and clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/41", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 20, "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/42", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-881d-736b-8f07-b074ed7dfeb5", "docSlug": "6a57ccf571f205aca9c4c1050696b3ed", "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "appendix_disclosure", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/43", "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5", "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/RzS0YDHLuwjiVuyr-NDHEmDUF-6XpFaBM3ogMiigs9Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNTFlMjBmM2E1YzRiNTAyNGMzZGJhMTNlMTMxNTUyOS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/1", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "b6641064-39fc-4a4c-95fd-ef69a064afff", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of operating highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/GdIN-OHZTUETG_cg7uEX_cGBNWGb12NdDasS9jmvLnI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNTFlMjBmM2E1YzRiNTAyNGMzZGJhMTNlMTMxNTUyOS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Lm--NzAGA5DrhhSUhfIrGu6JT3r7FnJNYG3R284noog/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNTFlMjBmM2E1YzRiNTAyNGMzZGJhMTNlMTMxNTUyOS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/nXFRpVHj9UmYuNY627POR2izSOGpjLyggNeUscgLN0E/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNTFlMjBmM2E1YzRiNTAyNGMzZGJhMTNlMTMxNTUyOS9wMDAxLnBuZw" }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/2", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "b6641064-39fc-4a4c-95fd-ef69a064afff", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of operating highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a background image of an Eos energy storage container.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/3", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "b6641064-39fc-4a4c-95fd-ef69a064afff", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of operating highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/4", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "9cbe84ee-0939-4ea0-9c52-e041357d54c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents Eos Z3 Transition and key takeaways", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "present_solution", "notes": "The slide uses a three-pillar structure to explain the transition from Gen 2.3 to Z3.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/5", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-5", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9bd8f891-6c1f-4017-910c-a4db24384913", "evidence": "The deck presents Eos Z3 Path to Profitability", "position": 0, "objective": "Highlighting the importance of Eos Z3", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "9cbe84ee-0939-4ea0-9c52-e041357d54c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents Eos Z3 Transition and key takeaways", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "present_solution", "notes": "The slide uses a three-column layout to categorize manufacturing progress into production status, system assembly, and future design.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/6", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-6", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9bd8f891-6c1f-4017-910c-a4db24384913", "evidence": "The deck presents Eos Z3 Path to Profitability", "position": 0, "objective": "Highlighting the importance of Eos Z3", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "e8b3c0f4-4e2a-4e4b-bd18-7d6fdc0b0fd2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents Eos Z3 Launch Update and Commercial Pipeline & Orders Backlog", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-88c2-709b-982c-188198b39bd3", "docSlug": "051e20f3a5c4b5024c3dba13e1315529", "documentTitle": "Eos Energy | Results Presentation Deck | 13 slides", "authorId": "eos-energy", "authorName": "Eos Energy Enterprises", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a dual-axis-like conceptual chart to show price vs cost convergence, with a callout for IRA impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-88c2-709b-982c-188198b39bd3/7", "deckHref": "/decks/019de075-88c2-709b-982c-188198b39bd3", "deckAnchorHref": "/decks/019de075-88c2-709b-982c-188198b39bd3#slide-7", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9bd8f891-6c1f-4017-910c-a4db24384913", "evidence": "The deck presents Eos Z3 Path to Profitability", "position": 0, "objective": "Highlighting the importance of Eos Z3", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "e8b3c0f4-4e2a-4e4b-bd18-7d6fdc0b0fd2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck presents Eos Z3 Launch Update and Commercial Pipeline & Orders Backlog", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }